U
RGDX

UBS’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

UBS’s Portfolio RGDX Stock Details RGDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Buy
+1,532
New +$1.2K ﹤0.01% 10249
2014
Q1 		– Sell
-33,244
Closed -$39K – 11269
2013
Q4 		$39K Buy
+33,244
New +$54.5K ﹤0.01% 7302
2013
Q3 		– Sell
-1,848
Closed -$3K – 11069
2013
Q2 		$3K Buy
+1,848
New +$2.52K ﹤0.01% 9710

Other funds holding RGDX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

UBS's RGDX Position: Q3 2014 in Review

UBS opened a new position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2014: 1,532 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #10249 among its holdings. This is a return to the name: UBS previously reported a position in RGDX as recently as Q4 2013.

UBS first reported a position in RGDX in Q2 2013 and has held it in 3 quarters since. The position peaked at $39K in Q4 2013. 18 funds tracked by Wall St. Rank hold RGDX as of Q3 2014.

  • UBS held 1,532 shares of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) worth $1K as of Q3 2014.
  • RESPONSE GENETICS, INC COMMON SHS (DELAWARE) was a new UBS position in Q3 2014.
  • RESPONSE GENETICS, INC COMMON SHS (DELAWARE) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10249 holding.
  • UBS first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q2 2013 and has held it in 3 quarters since.
  • UBS's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $39K in Q4 2013.
  • 18 funds tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.